v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Stock-based Compensation Expense
Stock-based compensation related to our stock-based awards and employee stock purchase plan for the three and six months ended June 30, 2026 and 2025 is as follows (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Cost of net revenues$1,846 $1,636 $3,466 $3,174 
Selling, general and administrative
33,011 33,485 62,003 64,351 
Research and development10,703 13,087 21,015 25,680 
Total stock-based compensation$45,560 $48,208 $86,484 $93,205 
Summary Of Restricted Stock Units
A summary for the six months ended June 30, 2026 is as follows:
Number of Shares
Underlying RSUs
(in thousands)
Weighted Average Grant Date Fair ValueWeighted Average Remaining
Contractual Term (in years)		Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2025
1,250 $256.80 
Granted
798 189.19 
Vested and released(452)283.14 
Forfeited(64)229.45 
Unvested as of June 30, 2026
1,532 $214.93 1.75$258,338 
Summary of MSU Performance Activity
The following table summarizes the MSU performance activity for the six months ended June 30, 2026: 
Number of Shares
Underlying MSUs
(in thousands)
Weighted Average Grant Date Fair Value
Weighted Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2025
263 $507.88 
Granted149 378.44 
Vested and released1
(63)622.37 
Forfeited(37)532.75 
Unvested as of June 30, 2026
312 $419.99 1.92$52,623 
1 Includes MSUs vested during the period below 100% of the original grant as actual shares released are based on our stock performance relative to a market index over the vesting period.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of the option component of the 2010 Purchase Plan shares was estimated at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:
Six Months Ended
June 30,
20262025
Expected term (in years)0.91.1
Expected volatility41.4 %40.9 %
Risk-free interest rate3.6 %4.2 %
Expected dividends— — 
Weighted average fair value at grant date$51.66 $70.62